Lion Licenses SRS to Incyte | GenomeWeb

NEW YORK, April 2 - Lion Bioscience has licensed its SRS bioinformatics platform to Incyte Genomics for three years, the German company said on Tuesday.

Financial terms of the deal were not disclosed, but Lion said it expects to pocket annual license fees and royalties from Incyte as well as from those Incyte customers that use the SRS-based software platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.